Universally implantable regenerative human tissues
Humacyte (humacyte.com) scores 80 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 71st percentile of 13165 Healthcare brands.
Humacyte is a biotechnology company headquartered in Morrisville, United States, founded in 2004. It develops and commercializes universally implantable, bioengineered human tissues designed to regenerate into the patient's own tissue, addressing unmet medical needs. Its proprietary decellularization process creates acellular tissue engineered vessels that retain key signaling proteins, prompting a patient's own cells to proliferate and transform the implant into native tissue. The company's platform is FDA-approved and designed for scalable commercial use, primarily targeting vascular repair and trauma applications.
| Brand Name | Humacyte |
|---|---|
| Domain | humacyte.com |
| Industry | Healthcare |
| Founded | 2004 |
| Headquarters | Morrisville |
| Main Competitors | Artivion (CryoLife) (79/100), W. L. Gore & Associates (Gore Medical), LeMaitre Vascular, Xeltis, Organogenesis (70/100) |
Moz Domain Authority 44/100 vs category average 41 / leader 97 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "To develop and commercialize universally implantable, bioengineered human tissues that regenerate into the patient's own tissue to address unmet medical needs." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 2 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, X (Twitter), Instagram, YouTube; no detected presence on Facebook, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Humacyte?", Claude could identify the brand as of October 2026. Humacyte is a biotechnology company developing bioengineered human tissue, most notably its acellular tissue engineered vessel (ATEV) made from human cells grown on a biodegradable scaffold, intended for use in vascular repair, trauma, and dialysis access. It went public via SPAC Best known for Developing bioengineered human acellular vessels (ATEV) for vascular trauma and repair without needing donor tissue.
When asked "Best brands similar to Humacyte?", Claude would recommend Humacyte as of October 2026. It's a notable name in regenerative medicine and tissue engineering, especially for vascular applications, so it would come up in discussions of innovative biotech addressing trauma and vascular repair.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Humacyte's main competitors in Healthcare: Artivion (CryoLife) (79/100), Organogenesis (70/100).
Sources: Brand Analyzer scan
Humacyte has limited AI-search visibility, scoring 42/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 55, recommendation 63). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Humacyte official site
Humacyte was founded in 2004. Humacyte operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Humacyte is headquartered in Morrisville. Humacyte operates in the Healthcare category.
Sources: Wikidata
Humacyte's core product is an acellular tissue engineered vessel, created through a proprietary decellularization process. This off-the-shelf biologic vessel is used for vascular repair and regeneration, designed to integrate into the body and transform into the patient's own native tissue over time.
Sources: Humacyte official site
Humacyte develops and commercializes universally implantable, bioengineered human tissues using a proprietary decellularization process to create acellular tissue engineered vessels. These vessels retain key proteins that signal a patient's own cells to proliferate and transform the implant into the patient's native tissue over time.
Sources: Humacyte official site
Humacyte scores 63/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Humacyte official site
Humacyte is a biotechnology company based in Morrisville, United States, founded in 2004, that develops bioengineered human tissue products for vascular repair and regeneration.
Sources: Humacyte official site
Humacyte can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Humacyte official site
Humacyte is known for pioneering an off-the-shelf, FDA-approved biologic vessel platform-acellular tissue engineered vessels created through a proprietary decellularization process-that can be implanted universally and regenerate into the patient's own tissue.
Sources: Humacyte official site
Humacyte's products are intended for use by healthcare providers and surgeons treating patients with vascular trauma and other conditions requiring vascular repair or tissue regeneration. Medical institutions and clinical researchers are also part of its target audience.
Sources: Humacyte official site
Humacyte scores 42/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Humacyte has a limited AI-visibility profile at 42/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (63/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a Moz Domain Authority of 44/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Humacyte from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Humacyte: Hudson Guild (80/100), Hennick Humber Hospital (80/100), Hydreight (80/100), Hypera Pharma (80/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.